par Cardoso, Fatima 
;Ross, Jeffrey S.;Piccart-Gebhart, Martine ;Sotiriou, Christos ;Durbecq, Virginie
Référence Clinical breast cancer, 5, 2, page (148-157)
Publication Publié, 2004-06
;Ross, Jeffrey S.;Piccart-Gebhart, Martine ;Sotiriou, Christos ;Durbecq, Virginie Référence Clinical breast cancer, 5, 2, page (148-157)
Publication Publié, 2004-06
Article révisé par les pairs
| Titre: |
|
| Auteur: | Cardoso, Fatima; Ross, Jeffrey S.; Piccart-Gebhart, Martine; Sotiriou, Christos; Durbecq, Virginie |
| Informations sur la publication: | Clinical breast cancer, 5, 2, page (148-157) |
| Statut de publication: | Publié, 2004-06 |
| Sujet CREF: | Sciences bio-médicales et agricoles |
| MeSH keywords: | Animals |
| Boronic Acids -- pharmacology | |
| Boronic Acids -- therapeutic use | |
| Breast Neoplasms -- drug therapy | |
| Breast Neoplasms -- enzymology | |
| Clinical Trials, Phase I as Topic | |
| Clinical Trials, Phase II as Topic | |
| Cysteine Endopeptidases -- drug effects | |
| Cysteine Endopeptidases -- physiology | |
| Disease Models, Animal | |
| Dose-Response Relationship, Drug | |
| Drug Administration Schedule | |
| Female | |
| Humans | |
| Mice | |
| Molecular Biology | |
| Multienzyme Complexes -- drug effects | |
| Multienzyme Complexes -- physiology | |
| NF-kappa B -- drug effects | |
| NF-kappa B -- metabolism | |
| Neoplasm Transplantation | |
| Proteasome Endopeptidase Complex | |
| Protein Transport -- drug effects | |
| Pyrazines -- pharmacology | |
| Pyrazines -- therapeutic use | |
| Risk Factors | |
| Sensitivity and Specificity | |
| Survival Rate | |
| Treatment Outcome | |
| Ubiquitin -- pharmacology | |
| Ubiquitin -- therapeutic use | |
| Note générale: | Journal Article |
| Review | |
| Langue: | Anglais |
| Identificateurs: | urn:issn:1526-8209 |
| info:pmid/15245620 |
